INTRODUCTION
In previous communications, we have reported the expression of a serologically and biochemically defined surface antigen on Moloney sarcoma virus (Mo-MSV) non-productively transformed Sac cells of STU mouse origin (Weiland et al., 1978; Hunsmann et al., 1980) . This antigen was not found on untransformed Moloney helper virus (Mo-MLV)-producing cells and was neither related serologically to structural polypeptides of murine C-type viruses nor to components of embryonal STU mouse fibroblasts and foetal bovine serum. Reinvestigation of this antigen revealed a cell surface glycoprotein with an apparent mol. wt. of 46000, here denoted the 46K antigen (H.-J. Thiel & E. Weiland, unpublished results) .
Sac non-producer (NP) cells failed to elicit anti-46K antibodies when inoculated into immunocompetent mice. Only transplantation of Mo-MLV-infected Sac cells led to anti-46K antibody development (Weiland et al., 1978) . In order to obtain more information about this antigen, further transformants of different aetiology were tested for expression of an antigen identical or related to 46K antigen. Monoclonal antibodies against the 46K antigen were raised for these studies. Application of these monoclonal antibodies led to the det~ection of only one further Mo-MSV NP transformant, PV-TC-77, induced with the progressor strain of Mo-MSV 0000-6524 © 1985 SGM (Weiland & Mussgay, 1980 , 1982 which expressed a surface antigen with the same molecular weight and biological properties as the Sac cell surface antigen. Therefore, two independently established Mo-MSV transformants (Weiland et al., 1978; Weiland & Mussgay, 1980 )expressed a cell surface antigen detectable by monoclonal antibodies against the 46K antigen.
METHODS

Cells.
The NP Sac cells originated from a secondary tumour of a STU mouse. Superinfection of these NP cells with Moloney helper virus derived from the syngeneic Bc cells (Weiland & Mussgay, 1976 ) generated the Sac producer cell line producing both Mo-MSV and helper virus. Details of their origin have been described previously (Weiland et al., 1978) . More recently, the derivation of transformants from tumours induced in adult STU mice after intramuscular (i.m.) inoculation of the progressor strain of Mo-MSV (progressor Mo-MSV) has been described by Weiland & Mussgay (1980) . Methylcholanthrene transformants were established from tumours induced in adult STU mice by i.m. application of 100 ~tg 3-methylcholanthrene (MCA; Serva, Heidelberg, F.R.G.) in 50 ~tl sesame oil. Sch/i-T-D represents a transformant derived from a spontaneous tumour in an older STU mouse (originally obtained from W. Sch/ifer, Max Planck-Institut fiir Virusforschung, Tfibingen, F.R.G. (Seifert et al., 1975) . Amphotropic murine helper virus (AP129) was made available to us through the courtesy of S. A. Aaronson.
Mice. STU inbred mice were originally obtained from W. Sch/ifer. They have been used in previous studies (Weiland & Mussgay, 1976; Weiland et al., 1978) .
Immunization with proliferation-inhibited Sac cells. Proliferation inhibition was done by irradiation (10000 rad)or incubation with mitomycin C (100 #g/107 cells/ml; Serva). At least six weekly applications of 5 x 106 to 107 cells were performed using Sac cells which were propagated as ascitic tumour cells to prevent immunization against constituents of culture medium. Further immunization trials were carried out with Sac cells mixed with complete (first immunization) and incomplete Freund's adjuvant (second immunization).
Infection of Sac non-producer cells with eeotropic and amphotropic murine C-type helper viruses. In the presence of Polybrene (2 ~g/ml) Sac cells were infected with ecotropic helper virus (Moloney and Friend) at an m.o.i, of 1 and with amphotropic murine helper virus (AP129) at an m.o.i, of 0.1. The helper virus-infected Sac cells were transferred twice weekly. Six weeks after infection they were transplanted i.m. into 6-to 8-week-old STU mice. Blood was collected about 6 to 7 weeks later from mice bearing small tumour nodules.
Production ofhybridomas. The myeloma cells NS-1 were used for fusion with spleen cells from STU mice. As spleen donors, mice were used after transplantation of Moloney helper virus-infected Sac cells. These producer,Sac cells lead to either progressor or regressor tumours, depending on the tumour cell' dose (Weiland et al., 1978) . Initially, spleens of repeatedly treated regressor mice were used for fusion experiments. In later experiments spleens from mice bearing tumours that developed after a single inoculation of Sac producer tumour cells were utilized. Screening of hybridoma supernatants was done with both a C'-dependent antibody-mediated microcytotoxicity assay using chromium-5 l-labelled Sac cells and a Protein A haemadsorption assay on Sac cells. Antibody activity against C-type helper virus antigens was tested with the same assays using Moloney helper virus-producing cells as targets (Bc; Weiland & Mussgay, 1976) . Positive cultures were cloned twice by limiting dilution and passaged as ascites in (STU x BALB/c)F~ mice.
Hybridoma antibody class. This was determined by microimmunodiffusion tests using standard antisera against the various murine immunoglobulins (Miles Laboratories).
Protein A haemadsorption assay (PA-H). The PA-H was performed according to Pfreundschuh et al. (1978) . Briefly, human O ÷ erythrocytes were labelled with Protein A in the presence of chromium chloride. Assays were performed with adhering culture cells in Falcon 3040 microtest II plates. Target cells (plated 1 to 2 days previously) and antibodies were incubated for 1 h at 37 °C. After the target cells were washed, indicator cells were added and incubated for a further hour at room temperature. The plates were then washed, and reactions were evaluated by light microscopy.
~25I-labelled Protein A binding assay. Since the described version of the Protein A haemadsorption assay was only applicable for culture cells adhering to culture vessels, a variant of a Protein A binding assay was established for adherent and non-adherent cells that allows investigation of both IgG and IgM antibody classes. In short, viable cells in suspension are incubated with mouse antibody, washed three times, then incubated with rabbit antimouse immunoglobulin. Following further washing, the complex was stabilized by fixation with freshly prepared 
The fusion experiment was done with a spleen taken 22 days after tumour cell transplantation. Development of hybridoma colonies was observed in all 72 culture wells (16 ram) until the 26th day after fusion. After two limiting dilution clonings, by hybridoma D56 antibody from the culture supernatant of about 105 hybridoma cells was demonstrable down to a dilution between 10 -5 and 10 -6 in a Protein A haemadsorption assay (PA-H).
t AMC, C'-dependent antibody-mediated cytotoxicity.
formaldehyde. Incubation with appropriate counts of l z5I-labelled Protein A followed. After three further washings, cell-bound c.p.m, were determined in a gamma counter.
Cytotoxicity assay. The C'-dependent humoral chromium release assay (AMC) was employed as a microcytotoxicity assay. Fifty ~tl of hybridoma supernatant were mixed with 25 ~tl chromium-labelled target cells (2.5 x 104 cells) in a well ofa microtitre plate. Following a 30min incubation in the cold, 75 ~1 ofpreselected rabbit serum preabsorbed with agarose and diluted 1:24, was added as complement. After an additional incubation for 1 h at 37 °C, 50 ~tl ice-cold phosphate-buffered saline was added. The plates were then centrifuged for 5 rain at 400 g and 100 ~1 of the supernatant fluid was harvested for c.p.m, determination in a gamma counter. Per cent specific chromium release was calculated according to the formula used by Orazo & Henney (1978) .
Cell surJace iodination, immunoprecipitation and analysis by SDS-PAGE.
Lactoperoxidase-catalysed cell surface iodination generally followed a published procedure (Deinhardt et al., 1978) . Immunoprecipitates were formed as described previously (Deinhardt et al., 1978) , analysed on slab gels (Laemmli, 1970) , and processed for fluorography according to Bonner & Laskey (1974) .
RESULTS
Production of hybridomas
Fusion experiments initially performed with spleen cells from STU mice exhibiting regression of a Sac producer cell-induced tumour did not lead to hybridomas producing antibodies against Sac NP surface antigen, although the spleen donors had shown distinct serum antibody titres against Sac NP cells in AMC (1:900) and PA-H (1:24000). Similar results were obtained after repeated transfers of Sac NP or producer cells into regressor mice. However, hybridomas producing antibodies against Sac NP cells were repeatedly obtained after fusion with spleen cells from mice bearing a tumour after one Sac producer cell inoculation. As shown in Table 1 (leading to a small tumour nodule which had a diameter of about 0.7 cm at the time of fusion) two hybridomas (designated D56 and E 14) could be established which stably produced antibodies against the Sac cell surface antigen after cloning twice.
Characterization of monoclonal antibodies against Sac surface antigen
Both hybridomas producing monoclonal antibody against Sac surface antigen had been detected by a screening assay using PA-H on Sac cells. Supernatant obtained from cultures comprising about 105 hybridoma cells mediated pronounced adsorption of Protein A-labelled erythrocytes up to a dilution between 10 -5 and 10 -6. The ~25I-labelled Protein A binding assay also performed with Sac cells was less sensitive. Hybridoma culture supernatant had to be used in much higher concentrations (diluted 1 "20 to 1" 160) to mediate distinct ~25I-labelled Protein A binding. According to agar gel diffusion, both monoclonal antibodies belong to Ig subclass IgG2a. In AMC the monoclonal antibodies against Sac surface antigen did not mediate cytotoxicity against Sac cells.
Lactoperoxidase-catalysed iodination of intact cells has been a very useful tool for the identification of molecules located at the cell surface (Trowbridge et al., 1975) . After surface In addition to gp70 and other proteins, the polyclonal serum specifically precipitated a 46000 mol. wt. protein (Fig. 1, lane 2) designated the 46K antigen. A co-migrating band was recognized by the monoclonal antibody (Fig. 1, lane 4) reactive with the Sac surface antigen (D56). If immunoprecipitation was first performed with either polyclonal or monoclonal antibody, the 46K antigen could not be precipitated afterwards by either antibody (data not shown). This sequential immunoprecipitation assay strongly suggests that both antibodies recognize the same 46K antigen. A molecule with the same migration characteristics could also be detected on Sac NP cells (data not shown) and we therefore conclude that the monoclonal antibody reacts with the 46K antigen.
Application o[monoclonal antibodies against Sac 46K antigen to murine tumour cells of different aetiologies
To obtain information about the possible existence of a surface antigen identical or related to the 46K antigen on Sac cells, the monoclonal antibodies were tested against transformants of STU and BALB/c mouse origin. In addition to Sac cells transformed with the regressor strain of Mo-MSV, no further murine regressor Mo-MSV transformants could be established (Weiland et al., 1979) . We succeeded, however, in establishing NP transformants from tumours induced in STU mice with the progressor strain of Mo-MSV (Weiland & Mussgay, 1980 , 1982 included in this study. All these transformants, listed in Table 2 , were assayed for reactivity with two monoclonal antibodies against Sac surface antigen 46K in two screening assays: a PA-H (applicable to adherent culture cells) and a 125I-labelled Protein A binding assay (applicable to adherent and non-adherent culture cells). In addition to Sac cells, one progressor Mo-MSV transformant, PV-TC-77, showed binding of monoclonal antibodies against 46K antigen in the 125I-labelled Protein A binding assay (Fig. 2, Table 2 ). Three further progressor Mo-MSV transformants, induced simultaneously with the same sarcoma virus pool in STU mice (Weiland & Mussgay, 1980) , did not show reactivity with monoclonal antibodies against the 46K antigen. The MCA transformants, the spontaneous transformant and the BALB/c mouse transformants of different aetiology were also not reactive with monoclonal antibodies against the 46K Sac surface antigen.
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For further analysis of surface reactivity with PV-TC-77 NP these cells were iodinated, reacted with polyclonal and monoclonal antibody against 46K antigen and analysed by SDS-PAGE (Fig. 3) . The precipitates contained a polypeptide with the same migration characteristics as the 46K antigen from Sac "cells ( Fig. 1) . Since a monoclonal antibody precipitated this antigen, we assume identity or close similarity with the 46K detectable on Sac cells. In summary, a monoclonal antibody against the 46K antigen was used in cell surfacespecific assays and it reacted with only one additional Mo-MSV-transformed cell line (PV-TC-77), but not with several other transformants including further tumour cells transformed with Mo-MSV.
Detailed investigation of the progressor Mo-MSV transformant P V-TC-112 unreactive with monoclonal antibodies against Sac surface antigen
Although induced simultaneously with an identical sarcoma virus pool in the same mouse strain (Weiland & Mussgay, 1980) , monoclonal antibodies against the 46K antigen reacted with only one out of four progressor Mo-MSV NP transformants. To investigate the possibility that detection of this surface antigen failed because of application of monoclonal antibodies with restricted epitope specificity, one of the progressor Mo-MSV transformants, PV-TC-112, was studied in more detail. After surface iodination of PV-TC-112 cells and incubation with polyclonal antibodies against the 46K antigen, analysis of the immunoprecipitates by SDS-PAGE did not reveal evidence for a reactive surface antigen (data not shown). In addition, we investigated whether transplantation of Mo-MLV-infected PV-TC-112 cells might be able to induce antibodies reactive with the 46K antigen, as was the case with Mo-MLV-infected Sac and PV-TC-77 cells (see below). Mice bearing tumours induced with Mo-MLV-infected PV-TC-112 cells developed antibodies reactive with gp70 of Mo-MLV (Fig. 4, lane 4) but not antibodies against 46K antigen of Sac cells. Since PV-TC-112 was also negative in the Protein A binding assay (Table 2) , different approaches did not allow demonstration of a surface antigen similar or identical to 46K from Sac cells.
Restoration of immunogenicity of Sac cell surface antigen 46K
Viable oncogenic Sac NP cells were not able to induce a detectable immune response against its surface antigen (Weiland et al., 1978) . Therefore, we wanted to determine whether repeated inoculation of proliferation-inhibited Sac NP cells could overcome the block in the effector phase of the immune response against 46K antigen. After six injections of proliferationinhibited Sac cells without Freund's adjuvant or two injections in the presence of Freund's adjuvant, antibody reactivity against the 46K antigen was not detectable. Since infection of Sac NP cells with Mo-MLV had restored the ability to induce antibody against the Sac NP antigen (Weiland et al., 1978) , we investigated whether other helper C-type viruses had the same effect. Sac NP cells were superinfected with a further ecotropic helper virus, Friend leukaemia virus (FLV), and a murine amphotropic C-type virus, AP129. Both released sarcoma helper virus complex. The helper virus-infected Sac cells were transplanted once in graded doses (106 to 103 cells) i.m. into adult STU mice. Tumours developed in all groups and showed ultimately a progressive tumour course. Blood was collected between 6 and 7 weeks after tumour cell transplantation from mice with small tumour nodules (diameters of about 1 cm or less). After transplantation of FLV-and AP129-infected Sac cells into adult STU mice, serum antibodies were found that reacted with Sac NP cells in AMC and PA-H (results not shown). Fig. 4 demonstrates that antiserum from mice transplanted with Mo-MLV-infected Sac cells precipitated gp70 and the 46K antigen from Mo-MLV-infected Sac cells (lanes 1 and 2) . Serum from mice bearing tumours after inoculation with AP 129-infected Sac cells precipitated the 46K antigen also (Fig. 4 , lane 5) but reacted only slightly with Mo-MLV gp70 of superinfected Sac cells.
Immunogenicity of 46K cell surface antigen on progressor Mo-MSV non-productively transformed PV-TC-77 cells
Since Sac NP expressing the 46K antigen did not elicit an immune response against surface antigen by the transplantation of NP cells into syngeneic immunocompetent mice (Weiland et al., 1978) , it was of interest to investigate how recipients of PV-TC-77 NP tumour cells also expressing a 46K surface antigen, would react. As was observed with Sac NP cells, PV-TC-77 NP cells also did not induce detectable serum antibodies against the 46K surface antigen. However, after superinfection with helper virus and transplantation of the Mo-MLV-infected PV-TC-77 cells, the animals developed antibodies that reacted not only with Moloney helper virus-producing Bc cells and Sac NP cells in AMC (Table 3) but also with Bc and Sac NP cells in PA-H. In addition, this polyclonal serum reacted with the 46K antigen on Sac cells (Fig. l, lane 3) and the antigen identical or similar to the 46K on PV-TC-77 NP cells (Fig. 3, lane 3) .
DISCUSSION
In this study, we report the production of two monoclonal antibodies reactive against a 46K glycoprotein from a Mo-MSV NP transformant of STU mouse origin (Sac) (Weiland et al., 1978) . Both monoclonal antibodies were screened against a panel of cultured murine transformants of different aetiology. In addition to Sac cells, a 46K surface protein was detected on a Mo-MSV transformant, PV-TC-77, established from a progressor Mo-MSV-induced STU mouse tumour (Weiland & Mussgay, 1980 , 1982 . Three further progressor Mo-MSV transformants did not react with monoclonal antibodies against the 46K antigen. STU mouse transformants spontaneously or chemically transformed, and BALB/c mouse transformants of different aetiology (transformed with Mo-MSV, SV40 or MCA) were also non-reactive.
Both transformants expressing the 46K antigen at their surface were established independently from each other. Sac cells derived from a STU mouse tumour, originally induced with the regressor strain of Mo-MSV (Weiland et al., 1978) , and PV-TC-77 cells derived from a progressor Mo-MSV-induced STU mouse tumour (Weiland & Mussgay, 1980) . Both NP transformants exhibited the same peculiarity. The NP tumour cells expressed the 46K surface antigen, but did not induce detectable antibody development against it. Only helper virussuperinfected Sac or PV-TC-77 producer cells elicited the production of specific antibodies (in addition to antibodies against helper virus antigens). In this study we were mainly concerned with two questions: (i) why is this surface antigen expressed on only two different Mo-MSV transformed cell lines and, (ii) why is the 46K molecule antigenic but not immunogenic on the surface of the two NP transformants? What might be responsible for the induction of immunogenicity of the 46K antigen by helper virus superinfection?
The 46K surface protein is probably not a viral gene product since: (i) antisera against synthetic, peptides derived from the v-mos sequence (kindly provided by T. Hunter, Salk Institute, San Diego, Ca., and S. A. Aaronson) did not specifically precipitate the 46K antigen (unpublished results) and, (ii) the antigen in question could not be detected on the surface of all established Mo-MSV-transformed cell lines tested. (iii) Mo-MSV rescued from Sac cells with AP129 led to transformation of mink, goat and dog cells, but not to expression of the 46K antigen (unpublished).
It should be pointed out, however, that the techniques employed might not be sensitive enough to always detect this antigen, especially since only cell surface-specific assays were used. In addition, only v-mos from Mo-MSV 124 has been sequenced (Reddy et al., 1980 (Reddy et al., , 1981 Van Beveren et al., 1981 a, b) and not the oncogenes from the Moloney sarcoma viruses used in these studies. According to unpublished data, the structure of the Mo-MSV provirus from Sac cells is different from v-mos in HT-1 and FG 10 cells. In particular, cleavage of DNA from Sac NP cells with the restriction enzyme SacI led to a 3.5 kb fragment in comparison to a 6.5 kb fragment obtained with HT-1 and FG 10 cells. Experiments with cloned proviral DNA are in progress (V. Erfle, personal communication) .
It still appears to be most likely that the 46K antigen is encoded by a cellular gene, which became activated after integration of Mo-MSV. Since the antigen could only be detected on the surface of certain Mo-MSV-transformed cell lines, a specific site(s) of integration may be necessary for activation of this gene.
Expression of certain cellular proteins after transformation such as p53 and p50 has been described in different systems (DeLeo et al., 1979; Rotter et al., 1980) . In contrast to these two molecules the 46K protein is glycosylated, but not detectably phosphorylated (unpublished) . Preliminary experiments with monoclonal antibody against p53 (kindly provided by A. DeLeo) did not reveal cross-reactivity between the 46K Sac surface antigen and p53.
The 46K antigen could not be precipitated by antisera against FLV p30, Rauscher leukaemia virus p15, FLV gp70, FLV p l5(E) and Mo-MLV (data not shown). Therefore, the relevant antigen probably does not possess either Mo-MLV env gene-or gag gene-coded determinants. Any relationship to the 55 000 mol. wt. protein induced in cells transformed by the mI strain of Mo-MSV (Wood et al., 1980) remains to be determined.
Regarding the mechanism responsible for induction of immunogenicity of the 46K antigen by helper virus superinfection of NP transformants, one has to consider at least two possibilities: the helper virus may either change the 46K molecule or may act on the host, somehow influencing immune regulation. In addition, incorporation of 46K antigen into virus (Hunsmann et al., 1980) may be sufficient to make the 46K antigen immunogenic. Sac cells infected with influenza V1 virus were transplanted to test this possibility with another budding virus not belonging to the C-type virus group. An immune response against the 46K antigen was not elicited (data not shown). However, a direct comparison with infection by mouse retroviruses is not possible, since the influenza virus lyses the infected cells.
It seems reasonable that a tumour cell lacking demonstrable surface antigenicity is able to escape the immunosurveillance in an immunocompetent host. However, this does not seem to correspond with the fact that the tumour cells express a serologically reactive surface antigen like 46K. The demonstration that a detectable tumour cell surface antigen does not induce an immune response indicates that tumour cells are able to escape immunosurveillance in spite of the existence of surface antigenicity. The described phenomenon may occur on tumour cells more frequently than known until now. The existence of the 46K antigen would not have been detected if classical transplantation protection assays were applied for the detection of a surface antigen on Sac NP cells, since Sac NP cell inoculation did not induce protection against a subsequent Sac NP transplant (Weiland et al., 1978) .
